Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2393476
Max Phase: Preclinical
Molecular Formula: C28H23N3O5S
Molecular Weight: 513.58
Molecule Type: Small molecule
Associated Items:
ID: ALA2393476
Max Phase: Preclinical
Molecular Formula: C28H23N3O5S
Molecular Weight: 513.58
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCOC(=O)/C(CC(=O)c1cccc2c1C(=O)c1ccccc1C2=O)=N\NC(=S)Nc1ccc(C)cc1
Standard InChI: InChI=1S/C28H23N3O5S/c1-3-36-27(35)22(30-31-28(37)29-17-13-11-16(2)12-14-17)15-23(32)20-9-6-10-21-24(20)26(34)19-8-5-4-7-18(19)25(21)33/h4-14H,3,15H2,1-2H3,(H2,29,31,37)/b30-22-
Standard InChI Key: ABFBBIWKGKZQTE-SWKFRHMKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 513.58 | Molecular Weight (Monoisotopic): 513.1358 | AlogP: 4.25 | #Rotatable Bonds: 7 |
Polar Surface Area: 113.93 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 11.14 | CX Basic pKa: | CX LogP: 6.13 | CX LogD: 6.13 |
Aromatic Rings: 3 | Heavy Atoms: 37 | QED Weighted: 0.12 | Np Likeness Score: -0.64 |
1. Marković V, Janićijević A, Stanojković T, Kolundžija B, Sladić D, Vujčić M, Janović B, Joksović L, Djurdjević PT, Todorović N, Trifunović S, Joksović MD.. (2013) Synthesis, cytotoxic activity and DNA-interaction studies of novel anthraquinone-thiosemicarbazones with tautomerizable methylene group., 64 [PMID:23644206] [10.1016/j.ejmech.2013.03.071] |
Source(1):